<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Parenchymal hypodensity is a proposed risk factor for <z:mp ids='MP_0001914'>hemorrhage</z:mp> after recombinant tissue plasminogen activator (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) thrombolysis for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In Buffalo, NY, and Houston, TX, the authors reviewed 70 patients who were treated with intravenous <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> for <z:hpo ids='HP_0011009'>acute</z:hpo> middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Two observers blinded to clinical outcome analyzed initial noncontrast head computed tomography (CT) scans </plain></SENT>
<SENT sid="3" pm="."><plain>Basal ganglia CT hypodensity was quantitated in Hounsfield units (HUs) </plain></SENT>
<SENT sid="4" pm="."><plain>Contralateral-ipsilateral difference in density was calculated using the asymptomatic side as a control </plain></SENT>
<SENT sid="5" pm="."><plain>Ictus time to <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> averaged 2.5 hours </plain></SENT>
<SENT sid="6" pm="."><plain>Six patients developed symptomatic intraparenchymal <z:mp ids='MP_0008817'>hematomas</z:mp> (2 fatal) </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:mp ids='MP_0001914'>hemorrhage</z:mp> group had more severe basal ganglia hypodensity (mean 7.5 +/- 1.4, range 6-10 HU) than the nonhemorrhage group (2.2 +/- 1.4, range 0-9 HU) (P &lt; .0001) </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:mp ids='MP_0001914'>hemorrhage</z:mp> group had hypodensity of &gt; 5 HU; the nonhemorrhage group had hypodensity of &lt; or = 4 HU, except 1 patient with hypodensity of 9 HU </plain></SENT>
<SENT sid="9" pm="."><plain>In predicting <z:mp ids='MP_0001914'>hemorrhage</z:mp>, the positive predictive value of hypodensity &gt; 5 HU was 86%; the negative predictive value was 100% </plain></SENT>
<SENT sid="10" pm="."><plain>Prethrombolysis NIH <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (NIHSS) deficit (P = .0007) and blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (P = .005) were also higher in the <z:mp ids='MP_0001914'>hemorrhage</z:mp> group </plain></SENT>
<SENT sid="11" pm="."><plain>Age, gender, smoking, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and ictus time to <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> infusion did not differ between the 2 groups </plain></SENT>
<SENT sid="12" pm="."><plain>Logistic regression indicated that basal ganglia hypodensity was the best single predictor of <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>Hypodensity and NIHSS score together predicted <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="14" pm="."><plain>The authors conclude that basal ganglia hypodensity quantified by CT may be a useful method of risk stratification to select <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="70" ids="34342">MCA</z:chebi> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients for thrombolytic therapy </plain></SENT>
</text></document>